Table 2.
Epidemiological and clinical characteristics comparing IATM versus MS group
| |
IATM |
MS |
p |
|---|---|---|---|
| group | group | ||
| N (%) |
74 (87) |
11 (13) |
|
| Age, mean (SD), y |
45 (16) |
28.2 (9.1) |
0.001a |
| Sex, male/female |
36/38 |
4/7 |
0.529 |
| Follow up, median (IQR), y |
2.9 (0.9–3.9) |
9.9 (2.7–17.8) |
<0.001a |
| Time to maximum deficit, mean (SD), d |
6.9 (7.2) |
8.5 (7) |
0.487 |
| Admission Rankin, Mean (SD) |
2.8 (1.2) |
2.45 (1.1) |
0.284 |
| Outcome Rankin Mean (SD) |
1.3 (1.3) |
1.8 (1.2) |
0.290 |
| Time onset-start treatment, mean (SD), d |
9 (8.1) |
2 (2.2) |
0.553 |
| Back pain, n (%) |
30 (40.5) |
5 (45.5) |
0.755 |
| Urinary sphincter dysfunction, n (%) |
41 (55.4) |
6 (54.5) |
0.603 |
| Anal sphincter dysfunction, n (%) |
10 (13.5) |
1 (9.1) |
0.566 |
| Previous infection, n (%) |
23 (31.1) |
4 (36.4) |
0.485 |
| Summer season/Not summer season, n (%) |
13/72(18.1)/59/72 (81.9) |
1/11 (9.1)/10/11 (90.9) |
0.460 |
| TM relapses, n (%) | 0/73 (0) | 5/11 (45.5) | <0.001a |
IATM: Idiopathic acute transverse myelitis.
MS: Multiple Sclerosis.
IQR: Interquartile range.
SD: Standard deviation.
TM: Transverse myelitis.
aSignificant after Bonferroni correction.